Literature DB >> 7353457

Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man.

V Maxwell, A Shulkes, J C Brown, T E Solomon, J H Walsh, M I Grossman.   

Abstract

Eight male subjects were given pentagastrin by intravenous infusion in doses of 25, 74, 222, 667, and 2000 ng/kg/hr, each dose for 30 min. On another day the same subjects were given the same doses of pentagastrin while gastric inhibitory polypeptide (GIP) was being infused intravenously in a dose of 2 microgram/kg/hr. At the 222 ng/kg/hr dose of pentagastrin, acid output was significantly lower with GIP; at all other doses of pentagastrin, acid output did not differ significantly in tests with and without GIP. Pepsin output in the tests with and without GIP did not differ significantly at any dose of pentagastrin. Plasma concentration of GIP, measured by radioimmunoassay, showed a mean +/- SE plateau level of 7.4 +/- 1.4 ng/ml during GIP infusion and 0.4 +/- 0.1 ng/ml peak level after a standard meal. We conclude that the increase in blood concentration of GIP produced by feeding is probably inadequate to cause significant inhibition of gastric acid or pepsin secretion in man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7353457     DOI: 10.1007/bf01308308

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances.

Authors:  I G Cleator; R H Gourlay
Journal:  Am J Surg       Date:  1975-08       Impact factor: 2.565

Review 2.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

3.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

4.  A modified hemoglobin substrate method for the estimation of pepsin in gastric juice.

Authors:  A Berstad
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

5.  Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.

Authors:  D K Andersen; D Elahi; J C Brown; J D Tobin; R Andres
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

6.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

7.  Gastric inhibitory polypeptide (GIP) is not the primary mediator of the enterogastrone action of fat in the dog.

Authors:  T Yamagishi; H T Debas
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

  7 in total
  9 in total

1.  A stereological evaluation of secretin and gastric inhibitory peptide-containing mucosal cells of the perinatal small intestine of the pig.

Authors:  C Van Ginneken; A Weyns
Journal:  J Anat       Date:  2004-10       Impact factor: 2.610

2.  Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls.

Authors:  Juris J Meier; Michael A Nauck; Bartholomaeus Kask; Jens J Holst; Carolyn F Deacon; Wolfgang E Schmidt; Baptist Gallwitz
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

3.  Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat.

Authors:  C C Tseng; L A Jarboe; S B Landau; E K Williams; M M Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

4.  Comparison of gastric inhibitory polypeptide and intraduodenal or intravenous fat on gastric acid secretion from vagally innervated and denervated canine stomach.

Authors:  S J Konturek; J Konturek; M Cieszkowski; R Ebert; W Creutzfeldt
Journal:  Dig Dis Sci       Date:  1986-01       Impact factor: 3.199

5.  Failure of gastric inhibitory polypeptide to inhibit pentagastrin-stimulated acid secretion in vagotomized human subjects.

Authors:  T C Simmons; I L Taylor; V Maxwell; J C Brown; M I Grossman
Journal:  Dig Dis Sci       Date:  1981-10       Impact factor: 3.199

6.  Inhibitory effect of intragastric glucose on gastric acid secretion and gastric emptying of liquids in man. Role of endogenous somatostatin, gastrin, and insulin.

Authors:  H Sasaki; M Nagulesparan; A Dubois; B Vasquez; E Straus; M L Sievers; R H Unger
Journal:  Dig Dis Sci       Date:  1983-06       Impact factor: 3.199

7.  Inhibition of gastric secretion and motility by simulated upper gastrointestinal haemorrhage: a response to facilitate haemostasis?

Authors:  G M Fullarton; E J Boyd; G P Crean; K Buchanan; K E McColl
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

8.  Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor.

Authors:  J Takeda; Y Seino; K Tanaka; H Fukumoto; T Kayano; H Takahashi; T Mitani; M Kurono; T Suzuki; T Tobe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 9.  Searching for the physiological role of glucose-dependent insulinotropic polypeptide.

Authors:  Jens Juul Holst; Johanne Agerlin Windeløv; Geke Aline Boer; Jens Pedersen; Berit Svendsen; Mikkel Christensen; Signe Torekov; Meena Asmar; Bolette Hartmann; Anne Nissen
Journal:  J Diabetes Investig       Date:  2016-04-18       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.